Ultragenyx Pharmaceutical Inc. (RARE) Earnings Per Share (EPS)
Ultragenyx Pharmaceutical Inc. (RARE) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | -$1.73 |
| 2019-12-31 | -$7.12 |
| 2020-12-31 | -$3.07 |
| 2021-12-31 | -$6.70 |
| 2022-12-31 | -$10.12 |
| 2023-12-31 | -$8.25 |
| 2024-12-31 | -$6.29 |
| 2025-12-31 | -$5.83 |
How RARE compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | -$3.74 |
| NTLA | Intellia Therapeutics Inc. | -$3.81 |
| ENTA | Enanta Pharmaceuticals Inc. | -$3.84 |
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| BHVN | Biohaven Ltd. | -$6.86 |
These are five companies in the same sector as RARE with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("RARE")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RARE | $14.92 | -4.45% | 3.44M |
| 3 | ||||
| 4 | ||||
| 5 |